InvestSMART

Singular Health Group Ltd (ASX:SHG)

ALERT: Price-sensitive ASX Announcement for SHG
Current share price for SHG : $0.195 -0.075 (-27.78%)+
Announcement
Release
24 Feb 2026 8:12AM
Price at Release
$0.270
Full Release
download
Summary
Singular Health Group Ltd's half-year financial report for the period ending 31 December 2025 details a net loss of $2,970,106, primarily due to substantial share-based payment expenses and increased operational costs for its 3DICOM® platform. Despite the financial loss, the company achieved significant operational milestones, advancing the deployment of its 3D medical imaging platform in the U.S., and progressing with clinical trials, regulatory compliance, and market engagement. The company's focus remains on expanding its market reach, driven by strategic hires and partnerships aimed at scaling its technology globally.
Key Points
  • Net loss of $2,970,106 for the half-year ended 31 December 2025.
  • Significant share-based payment expenses amounted to $1,009,578.
  • Operational costs increased due to product development and expansion.
  • 3DICOM® platform deployment advanced in the U.S. market.
  • Strategic hires made in Singapore and the USA to support growth.
  • Revenue from contracts in the U.S. was $450,743 and in Australia $28,552.
  • Focus on scaling the 3D medical imaging platform globally.
  • The U.S. market presents a significant opportunity with an estimated TAM of US$16.5B.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.